RFA-CA-20-031 |
See Related
|
NCI |
04/14/2020 |
06/24/2020
|
06/25/2021
|
D43
|
Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed) |
RFA-MH-20-620 |
See Related
|
NIMH |
09/25/2020 |
11/07/2020
|
12/10/2022
|
F32
|
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
RFA-DK-19-032 |
See Related
|
NIDDK |
01/16/2020 |
03/14/2020
|
03/03/2021
|
F99/K00
|
KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) |
RFA-NS-19-011 |
See Related
|
NINDS |
10/03/2018 |
11/13/2018
|
04/16/2021
|
F99/K00
|
NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00) |
RFA-OD-20-011 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K01
|
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) |
RFA-OD-20-008 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K01
|
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) |
RFA-HL-19-025 |
See Related
|
NHLBI |
07/19/2018 |
09/10/2018
|
05/07/2021
|
K01
|
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) |
RFA-HL-19-026 |
See Related
|
NHLBI |
07/19/2018 |
09/10/2018
|
05/07/2021
|
K01
|
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) |
RFA-HL-20-006 |
See Related
|
NHLBI |
09/09/2019 |
10/18/2019
|
01/15/2022
|
K38
|
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) |
RFA-AG-21-021 |
See Related
|
NIA |
08/13/2020 |
01/03/2021
|
10/22/2022
|
K76
|
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) |
RFA-AG-21-020 |
See Related
|
NIA |
08/13/2020 |
01/03/2021
|
10/22/2022
|
K76
|
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) |
RFA-CA-20-057 |
See Related
|
NCI |
10/28/2020 |
01/26/2021
|
02/27/2021
|
K99/R00
|
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) |
RFA-CA-20-056 |
See Related
|
NCI |
10/28/2020 |
01/26/2021
|
02/27/2021
|
K99/R00
|
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed) |
RFA-CA-20-055 |
See Related
|
NCI |
10/28/2020 |
01/26/2021
|
02/27/2021
|
K99/R00
|
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
RFA-OD-20-010 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K99/R00
|
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) |
RFA-OD-20-009 |
See Related
|
ODP |
02/07/2020 |
06/08/2020
|
07/11/2022
|
K99/R00
|
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) |
RFA-NS-19-043 |
See Related
|
NINDS |
11/14/2019 |
01/09/2020
|
11/12/2022
|
K99/R00
|
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) |
RFA-NS-19-044 |
See Related
|
NINDS |
11/14/2019 |
01/10/2020
|
11/12/2022
|
K99/R00
|
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) |
RFA-CA-21-011 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
P01
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
RFA-HD-21-023 |
See Related
|
NICHD |
08/17/2020 |
02/26/2021
|
04/01/2021
|
P01
|
NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) |
RFA-CA-19-052 |
See Related
|
NCI |
09/05/2019 |
09/24/2019
|
06/24/2021
|
P01
|
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) |
RFA-DK-20-033 |
See Related
|
NIDDK |
11/16/2020 |
02/18/2021
|
03/19/2021
|
P20
|
Exploratory Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Optional) |
RFA-AI-21-001 |
See Related
|
NIAID |
01/07/2021 |
05/15/2021
|
06/16/2021
|
P30
|
Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed) |
RFA-DK-20-025 |
See Related
|
NIDDK |
11/19/2020 |
04/20/2021
|
05/21/2021
|
P30
|
Diabetes Research Centers (P30 Clinical Trial Optional) |
RFA-ES-20-006 |
See Related
|
NIEHS |
01/28/2020 |
04/18/2020
|
04/15/2022
|
P30
|
Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) |
RFA-DK-19-004 |
See Related
|
NIDDK |
03/13/2019 |
10/01/2019
|
07/02/2021
|
P30
|
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) |
RFA-OD-20-002 |
See Related
|
ORIP |
01/08/2020 |
01/20/2020
|
01/08/2023
|
P40
|
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) |
RFA-ES-20-014 |
See Related
|
NIEHS |
09/02/2020 |
01/15/2021
|
02/16/2021
|
P42
|
Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) |
RFA-AR-22-001 |
See Related
|
NIAMS |
12/09/2020 |
04/11/2021
|
05/12/2021
|
P50
|
NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed) |
RFA-CA-21-012 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
P50
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
RFA-HD-22-003 |
See Related
|
NICHD |
11/19/2020 |
02/28/2021
|
11/30/2021
|
P50
|
Contraceptive Development Research Centers Program (P50 Clinical Trial Optional) |
RFA-NS-21-001 |
See Related
|
NINDS |
07/15/2020 |
08/28/2020
|
09/27/2022
|
P50
|
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional) |
RFA-CA-19-053 |
See Related
|
NCI |
09/05/2019 |
09/24/2019
|
06/24/2021
|
P50
|
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) |
RFA-AG-21-034 |
See Related
|
NIA |
01/15/2021 |
02/28/2021
|
04/01/2021
|
R01
|
Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional) |
RFA-MH-21-145 |
See Related
|
NIMH |
01/11/2021 |
02/18/2021
|
03/19/2021
|
R01
|
HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) |
RFA-AG-21-033 |
See Related
|
NIA |
01/08/2021 |
02/18/2021
|
03/19/2021
|
R01
|
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
RFA-HL-21-014 |
See Related
|
NHLBI |
01/06/2021 |
02/15/2021
|
10/16/2021
|
R01
|
Understanding and Reducing Cardiovascular Disease in Type 1 Diabetes Mellitus (R01 Clinical Trial Optional) |
RFA-AG-22-006 |
See Related
|
NIA |
01/04/2021 |
05/17/2021
|
06/18/2021
|
R01
|
New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed) |
RFA-AA-21-001 |
See Related
|
NIAAA |
12/28/2020 |
02/15/2021
|
03/16/2021
|
R01
|
Improving Health Disparities in Alcohol Health Services (R01 Clinical Trial Optional) |
RFA-DA-21-040 |
See Related
|
NIDA |
12/28/2020 |
01/09/2021
|
02/10/2021
|
R01
|
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed) |
RFA-AG-22-002 |
See Related
|
NIA |
12/10/2020 |
05/15/2021
|
06/16/2021
|
R01
|
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed) |
RFA-MH-21-116 |
See Related
|
NIMH |
12/09/2020 |
02/10/2021
|
03/11/2021
|
R01
|
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R01 Clinical Trial Optional) |
RFA-CA-21-017 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
R01
|
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) |
RFA-CA-21-007 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
R01
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
RFA-ES-21-001 |
See Related
|
NIEHS |
11/19/2020 |
01/26/2021
|
02/25/2023
|
R01
|
Outstanding New Environmental Scientist (ONES) Award (R01 Clinical Trial Optional) |
RFA-MH-21-105 |
See Related
|
NIMH |
11/18/2020 |
01/09/2021
|
02/10/2021
|
R01
|
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) |
RFA-MH-21-160 |
See Related
|
NIMH |
11/18/2020 |
02/18/2021
|
03/19/2021
|
R01
|
Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) |
RFA-MH-21-110 |
See Related
|
NIMH |
11/13/2020 |
01/18/2021
|
06/16/2022
|
R01
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) |
RFA-DK-20-030 |
See Related
|
NIDDK |
11/13/2020 |
02/03/2021
|
03/04/2021
|
R01
|
Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed) |
RFA-MH-21-140 |
See Related
|
NIMH |
10/21/2020 |
02/10/2021
|
03/11/2022
|
R01
|
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed) |
RFA-AI-20-076 |
See Related
|
NIAID |
10/20/2020 |
02/17/2021
|
03/18/2023
|
R01
|
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) |
RFA-ES-20-018 |
See Related
|
NIEHS |
10/13/2020 |
01/02/2021
|
02/02/2021
|
R01
|
Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01 Clinical Trial Not Allowed) |
RFA-AI-20-057 |
See Related
|
NIAID |
09/29/2020 |
01/22/2021
|
02/23/2021
|
R01
|
Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed) |
RFA-HL-21-018 |
See Related
|
NHLBI |
09/24/2020 |
12/11/2020
|
12/15/2021
|
R01
|
Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed) |
RFA-AI-20-055 |
See Related
|
NIAID |
09/24/2020 |
01/11/2021
|
02/12/2021
|
R01
|
Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed) |
RFA-CA-20-046 |
See Related
|
NCI |
09/23/2020 |
11/13/2020
|
12/15/2021
|
R01
|
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
RFA-CA-20-051 |
See Related
|
NCI |
09/15/2020 |
02/15/2021
|
01/19/2022
|
R01
|
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) |
RFA-DK-20-023 |
See Related
|
NIDDK |
09/01/2020 |
02/03/2021
|
11/18/2021
|
R01
|
Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional) |
RFA-DK-20-022 |
See Related
|
NIDDK |
08/24/2020 |
02/03/2021
|
11/18/2021
|
R01
|
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional) |
RFA-ES-20-013 |
See Related
|
NIEHS |
08/24/2020 |
01/11/2021
|
02/12/2021
|
R01
|
RESolution of InflammaTion in EnvirOnmentally Related diseasE (RESTORE) (R01 Clinical Trial Not Allowed) |
RFA-HG-20-048 |
See Related
|
NHGRI |
07/30/2020 |
09/28/2020
|
07/09/2021
|
R01
|
Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional) |
RFA-EB-20-002 |
See Related
|
NIBIB |
06/29/2020 |
08/14/2020
|
09/15/2021
|
R01
|
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) |
RFA-EB-20-001 |
See Related
|
NIBIB |
06/29/2020 |
08/03/2020
|
09/04/2021
|
R01
|
BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) |
RFA-HG-20-036 |
See Related
|
NHGRI |
06/04/2020 |
07/03/2020
|
03/14/2023
|
R01
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R01) |
RFA-MH-20-525 |
See Related
|
NIMH |
04/06/2020 |
05/20/2020
|
06/21/2022
|
R01
|
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) |
RFA-HG-20-014 |
See Related
|
NHGRI |
03/19/2020 |
05/25/2020
|
02/05/2022
|
R01
|
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) |
RFA-CA-20-027 |
See Related
|
NCI |
03/16/2020 |
06/30/2020
|
07/31/2021
|
R01
|
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) |
RFA-MH-20-128 |
See Related
|
NIMH |
02/24/2020 |
08/03/2020
|
09/03/2021
|
R01
|
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) |
RFA-FD-21-001 |
See Related
|
FDA |
02/19/2020 |
08/06/2020
|
10/06/2021
|
R01
|
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required |
RFA-NS-20-006 |
See Related
|
NINDS |
01/02/2020 |
02/24/2020
|
10/04/2022
|
R01
|
BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) |
RFA-OD-20-005 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R01
|
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
RFA-MH-20-510 |
See Related
|
NIMH |
11/25/2019 |
02/02/2020
|
03/02/2022
|
R01
|
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) |
RFA-MH-20-505 |
See Related
|
NIMH |
11/25/2019 |
01/10/2020
|
07/02/2021
|
R01
|
Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R01 Clinical Trial Optional) |
RFA-MH-20-350 |
See Related
|
NIMH |
11/21/2019 |
01/10/2020
|
06/11/2021
|
R01
|
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) |
RFA-TR-20-001 |
See Related
|
NCATS |
10/23/2019 |
01/06/2020
|
10/07/2021
|
R01
|
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional) |
RFA-OD-19-029 |
See Related
|
ORWH |
09/27/2019 |
10/25/2019
|
11/27/2021
|
R01
|
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
RFA-OD-19-028 |
See Related
|
ODP |
09/25/2019 |
01/13/2020
|
02/14/2021
|
R01
|
Tobacco Regulatory Science (R01 Clinical Trial Optional) |
RFA-CA-19-049 |
See Related
|
NCI |
09/05/2019 |
09/24/2019
|
06/24/2021
|
R01
|
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) |
RFA-MH-20-120 |
See Related
|
NIMH |
04/10/2019 |
08/06/2019
|
02/27/2021
|
R01
|
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
RFA-MH-20-135 |
See Related
|
NIMH |
04/08/2019 |
08/27/2019
|
05/28/2021
|
R01
|
BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed) |
RFA-MH-19-147 |
See Related
|
NIMH |
07/17/2018 |
08/27/2018
|
03/05/2021
|
R01
|
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
RFA-NS-18-020 |
See Related
|
NINDS |
03/14/2018 |
04/15/2018
|
05/05/2021
|
R01
|
BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed) |
RFA-MH-18-707 |
See Related
|
NIMH |
11/14/2017 |
01/14/2018
|
02/19/2021
|
R01
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01- Clinical Trial Required) |
RFA-MH-18-701 |
See Related
|
NIMH |
11/14/2017 |
01/14/2018
|
02/19/2021
|
R01
|
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01- Clinical Trial Required) |
RFA-MH-18-700 |
See Related
|
NIMH |
11/14/2017 |
01/14/2018
|
02/19/2021
|
R01
|
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01-Clinical Trial Required) |
RFA-RM-21-007 |
See Related
|
RMOD |
11/06/2020 |
01/19/2021
|
03/20/2021
|
R03
|
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) |
RFA-OD-20-006 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R03
|
Small Research Grants for Analyses of Down Syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) |
RFA-HL-20-029 |
See Related
|
NHLBI |
10/17/2019 |
11/02/2019
|
01/11/2022
|
R03
|
Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 - Clinical Trial Optional) |
RFA-EY-21-001 |
See Related
|
NEI |
01/15/2021 |
04/02/2021
|
10/28/2023
|
R21
|
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
RFA-DA-21-041 |
See Related
|
NIDA |
12/28/2020 |
01/09/2021
|
02/10/2021
|
R21
|
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed) |
RFA-MH-21-117 |
See Related
|
NIMH |
12/09/2020 |
02/10/2021
|
03/11/2021
|
R21
|
Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional) |
RFA-CA-21-013 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
R21
|
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
RFA-CA-21-005 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/30/2021
|
R21
|
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
RFA-CA-21-003 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/30/2021
|
R21
|
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) |
RFA-MH-21-106 |
See Related
|
NIMH |
11/18/2020 |
01/09/2021
|
02/10/2021
|
R21
|
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) |
RFA-HG-20-049 |
See Related
|
NHGRI |
07/30/2020 |
09/28/2020
|
07/09/2021
|
R21
|
Investigator-Initiated Research on Genetic Counseling Processes and Practices (R21, Clinical Trial Optional) |
RFA-HG-20-037 |
See Related
|
NHGRI |
06/04/2020 |
07/03/2020
|
03/14/2023
|
R21
|
Advancing Genomic Medicine Research (Clinical Trial Optional) (R21) |
RFA-HG-20-015 |
See Related
|
NHGRI |
03/19/2020 |
05/25/2020
|
02/05/2022
|
R21
|
Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed) |
RFA-CA-20-028 |
See Related
|
NCI |
03/16/2020 |
06/30/2020
|
07/31/2021
|
R21
|
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) |
RFA-OD-20-004 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R21
|
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
RFA-MH-20-351 |
See Related
|
NIMH |
11/21/2019 |
01/10/2020
|
06/11/2021
|
R21
|
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) |
RFA-ES-19-011 |
See Related
|
NIEHS |
07/31/2019 |
10/01/2019
|
10/04/2022
|
R21
|
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) |
RFA-OD-19-022 |
See Related
|
ODP |
07/08/2019 |
09/09/2019
|
03/09/2021
|
R21
|
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
RFA-OD-19-021 |
See Related
|
ODP |
07/08/2019 |
09/09/2019
|
03/09/2021
|
R21
|
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) |
RFA-DC-19-001 |
See Related
|
NIDCD |
07/03/2018 |
09/04/2018
|
06/05/2021
|
R21/R33
|
NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional) |
RFA-DA-21-029 |
See Related
|
NIDA |
01/11/2021 |
02/26/2021
|
03/27/2021
|
R24
|
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Coordination and Dissemination Center (R24 Clinical Trial Optional) |
RFA-MH-20-600 |
See Related
|
NIMH |
08/07/2020 |
06/14/2021
|
07/15/2023
|
R24
|
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) |
RFA-OD-19-027 |
See Related
|
ORIP |
09/11/2019 |
09/28/2019
|
09/09/2022
|
R24
|
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) |
RFA-HL-22-009 |
See Related
|
NHLBI |
11/30/2020 |
02/08/2021
|
03/09/2021
|
R25
|
Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed) |
RFA-DK-20-020 |
See Related
|
NIDDK |
10/19/2020 |
11/22/2020
|
11/10/2022
|
R25
|
NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed) |
RFA-DC-20-002 |
See Related
|
NIDCD |
09/22/2020 |
09/23/2020
|
06/14/2023
|
R25
|
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) |
RFA-ES-20-015 |
See Related
|
NIEHS |
07/20/2020 |
10/30/2020
|
11/29/2022
|
R25
|
NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed) |
RFA-HL-19-024 |
See Related
|
NHLBI |
05/01/2018 |
08/10/2018
|
05/07/2021
|
R25
|
Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25 Clinical Trial Not Allowed) |
RFA-CA-21-006 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/30/2021
|
R33
|
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
RFA-CA-21-004 |
See Related
|
NCI |
11/20/2020 |
01/22/2021
|
09/29/2021
|
R33
|
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
RFA-HL-20-028 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R33
|
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) |
RFA-HL-20-027 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R33
|
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) |
RFA-HL-20-022 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R33
|
Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) |
RFA-MH-18-703 |
See Related
|
NIMH |
11/14/2017 |
01/14/2018
|
02/19/2021
|
R33
|
Early Stage Testing of Pharmacologic or Device -based Interventions for the Treatment of Mental Health Disorders (R33- Clinical Trial Required) |
RFA-DK-20-032 |
See Related
|
NIDDK |
01/06/2021 |
05/22/2021
|
06/23/2023
|
R34
|
Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required) |
RFA-MH-21-111 |
See Related
|
NIMH |
11/13/2020 |
01/18/2021
|
06/16/2022
|
R34
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) |
RFA-MH-20-500 |
See Related
|
NIMH |
04/15/2020 |
09/19/2020
|
06/16/2021
|
R34
|
Post-Acute Interventions for the Treatment of Anorexia Nervosa (R34 Clinical Trial Required) |
RFA-MH-20-506 |
See Related
|
NIMH |
11/25/2019 |
01/10/2020
|
07/02/2021
|
R34
|
Practice-Based Research for Implementing Scalable Evidence-Based Prevention Interventions in Primary Care Settings (R34 Clinical Trial Required) |
RFA-NS-18-014 |
See Related
|
NINDS |
12/14/2017 |
02/15/2018
|
11/10/2021
|
R34
|
BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 - Clinical Trials Not Allowed) |
RFA-MH-18-706 |
See Related
|
NIMH |
11/14/2017 |
01/14/2018
|
02/19/2021
|
R34
|
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required) |
RFA-HL-20-012 |
See Related
|
NHLBI |
01/25/2019 |
02/14/2019
|
04/16/2021
|
R35
|
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) |
RFA-HL-20-011 |
See Related
|
NHLBI |
01/25/2019 |
02/14/2019
|
04/16/2021
|
R35
|
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) |
RFA-ES-21-003 |
See Related
|
NIEHS |
12/10/2020 |
02/28/2021
|
03/30/2021
|
R41
|
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed) |
RFA-DA-21-015 |
See Related
|
NIDA |
12/23/2020 |
01/26/2021
|
02/27/2021
|
R41/R42
|
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R41/R42 - Clinical Trials Optional) |
RFA-DA-21-031 |
See Related
|
NIDA |
12/22/2020 |
12/26/2020
|
02/27/2021
|
R41/R42
|
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) |
RFA-NS-20-008 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R41/R42
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) |
RFA-NS-20-009 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R41/R42
|
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) |
RFA-DA-19-020 |
See Related
|
NIDA |
12/10/2018 |
12/10/2018
|
09/09/2021
|
R41/R42
|
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional) |
RFA-CA-21-001 |
See Related
|
NCI |
11/25/2020 |
02/10/2021
|
03/11/2021
|
R42
|
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) |
RFA-ES-21-002 |
See Related
|
NIEHS |
12/10/2020 |
02/28/2021
|
03/30/2021
|
R43
|
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R43 Clinical Trial Not Allowed) |
RFA-DA-21-016 |
See Related
|
NIDA |
12/23/2020 |
01/26/2021
|
02/27/2021
|
R43/R44
|
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional) |
RFA-DA-21-032 |
See Related
|
NIDA |
12/22/2020 |
12/26/2020
|
01/27/2021
|
R43/R44
|
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) |
RFA-MH-21-112 |
See Related
|
NIMH |
11/13/2020 |
01/18/2021
|
06/16/2022
|
R43/R44
|
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) |
RFA-HG-20-016 |
See Related
|
NHGRI |
03/19/2020 |
05/25/2020
|
02/05/2022
|
R43/R44
|
Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed) |
RFA-NS-20-011 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R43/R44
|
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) |
RFA-NS-20-010 |
See Related
|
NINDS |
10/04/2019 |
12/08/2019
|
09/09/2022
|
R43/R44
|
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) |
RFA-DA-19-019 |
See Related
|
NIDA |
12/10/2018 |
12/10/2018
|
09/09/2021
|
R43/R44
|
HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional) |
RFA-DK-21-001 |
See Related
|
NIDDK |
01/13/2021 |
03/22/2021
|
11/04/2021
|
R61/R33
|
Biomarkers for Diabetic Foot Ulcers through the Diabetic Foot Consortium (R61/R33 Clinical Trial Not Allowed) |
RFA-HL-21-013 |
See Related
|
NHLBI |
04/30/2020 |
06/24/2020
|
06/02/2022
|
R61/R33
|
Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required) |
RFA-HL-22-006 |
See Related
|
NHLBI |
04/16/2020 |
02/05/2021
|
05/08/2021
|
R61/R33
|
Implementation Research to Improve Case Finding, Cascade Screening, and Treatment for Familial Hypercholesterolemia (FH) (R61/R33 Clinical Trial Required) |
RFA-DA-21-005 |
See Related
|
NIDA |
03/24/2020 |
07/13/2020
|
08/14/2021
|
R61/R33
|
Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional) |
RFA-OD-20-003 |
See Related
|
NIH |
12/13/2019 |
01/14/2020
|
11/04/2021
|
R61/R33
|
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |
RFA-HL-20-024 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R61/R33
|
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) |
RFA-HL-20-023 |
See Related
|
NHLBI |
09/09/2019 |
10/08/2019
|
08/12/2021
|
R61/R33
|
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) |
RFA-HL-20-021 |
See Related
|
NHLBI |
09/03/2019 |
09/17/2019
|
12/22/2021
|
R61/R33
|
Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) |
RFA-MH-18-704 |
See Related
|
NIMH |
11/14/2017 |
01/14/2018
|
02/19/2021
|
R61/R33
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required) |
RFA-MH-18-702 |
See Related
|
NIMH |
11/14/2017 |
01/14/2018
|
02/19/2021
|
R61/R33
|
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required) |
RFA-DA-21-030 |
See Related
|
NIDA |
01/11/2021 |
02/26/2021
|
03/27/2021
|
RM1
|
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) |
RFA-MH-20-555 |
See Related
|
NIMH |
11/26/2019 |
01/10/2020
|
10/09/2021
|
S10
|
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed) |
RFA-OH-20-003 |
See Related
|
NIOSH |
11/21/2019 |
11/22/2019
|
01/30/2022
|
T03
|
Commercial Fishing Occupational Safety Training Project Grants (T03) |
RFA-AG-21-027 |
See Related
|
NIA |
10/07/2020 |
01/03/2021
|
02/04/2021
|
T32
|
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed) |
RFA-HL-19-023 |
See Related
|
NHLBI |
04/27/2018 |
08/04/2018
|
05/07/2021
|
T32
|
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) |
RFA-FD-21-021 |
See Related
|
FDA |
01/13/2021 |
01/18/2021
|
03/19/2021
|
U01
|
Renewal - Elucidating the Sensorial and Functional Characteristics of Compositionally Different and Differently Aged Topical Formulations (U01) Clinical Trial Required |
RFA-AI-20-077 |
See Related
|
NIAID |
01/12/2021 |
05/04/2021
|
06/05/2021
|
U01
|
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) |
RFA-DA-21-021 |
See Related
|
NIDA |
01/11/2021 |
03/01/2021
|
04/01/2021
|
U01
|
HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed) |
RFA-DA-21-020 |
See Related
|
NIDA |
01/11/2021 |
03/01/2021
|
04/01/2021
|
U01
|
HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed) |
RFA-FD-21-027 |
See Related
|
FDA |
01/07/2021 |
01/18/2021
|
03/19/2021
|
U01
|
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning (U01) Clinical Trials Not Allowed |
RFA-FD-21-018 |
See Related
|
FDA |
01/07/2021 |
01/15/2021
|
03/16/2021
|
U01
|
Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans (U01) Clinical Trial Not Allowed |
RFA-FD-21-016 |
See Related
|
FDA |
01/07/2021 |
01/18/2021
|
04/01/2021
|
U01
|
Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01) Clinical Trials Not Allowed |
RFA-FD-21-023 |
See Related
|
FDA |
01/07/2021 |
01/08/2021
|
03/10/2021
|
U01
|
National Food and Nutrient Analysis Program (U01) Clinical Trial Not Applicable |
RFA-DK-20-508 |
See Related
|
NIDDK |
01/07/2021 |
03/14/2021
|
04/15/2021
|
U01
|
Limited Competition: Revision to the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) |
RFA-FD-21-015 |
See Related
|
FDA |
01/06/2021 |
01/12/2021
|
03/16/2021
|
U01
|
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Inhalation Products (U01) Clinical Trials Optional |
RFA-FD-21-012 |
See Related
|
FDA |
01/06/2021 |
01/15/2021
|
03/16/2021
|
U01
|
Physiologically Based Pharmacokinetic (PBPK) Models of Oral Absorption to Simulate the Results of Bioequivalence Studies (U01) Clinical Trials Optional |
RFA-NS-21-017 |
See Related
|
NINDS |
01/06/2021 |
02/15/2021
|
03/16/2021
|
U01
|
Next Generation Sequencing in Post Mortem Tissue from Patients with Parkinsons Disease (U01 Clinical Trial Not Allowed) |
RFA-FD-21-010 |
See Related
|
FDA |
12/10/2020 |
12/14/2020
|
02/13/2021
|
U01
|
Renewal - Research, Education, and Outreach on Botanical Natural Products (U01) Clinical Trial Not Allowed |
RFA-FD-21-014 |
See Related
|
FDA |
12/09/2020 |
12/15/2020
|
02/16/2021
|
U01
|
Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01) Clinical Trials Optional |
RFA-FD-21-013 |
See Related
|
FDA |
12/09/2020 |
12/15/2020
|
02/16/2021
|
U01
|
Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional |
RFA-FD-21-006 |
See Related
|
FDA |
12/03/2020 |
12/03/2020
|
02/02/2021
|
U01
|
Renewal - Cooperative Agreement to Support Shellfish Assistance Project (U01) Clinical Trial Not Allowed |
RFA-CA-21-018 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U01
|
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) |
RFA-CA-21-014 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U01
|
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) |
RFA-CA-21-008 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
U01
|
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
RFA-NS-21-005 |
See Related
|
NINDS |
11/23/2020 |
02/09/2021
|
03/10/2021
|
U01
|
Small Vessel VCID Biomarker Validation Consortium Sites (U01)(Clinical Trials Not Allowed) |
RFA-DK-20-013 |
See Related
|
NIDDK |
11/23/2020 |
01/18/2021
|
02/19/2021
|
U01
|
GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Atlas Projects (U01 Clinical Trial Not Allowed) |
RFA-NS-21-008 |
See Related
|
NINDS |
10/28/2020 |
02/02/2021
|
03/03/2021
|
U01
|
Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) |
RFA-AA-20-013 |
See Related
|
NIAAA |
10/14/2020 |
04/26/2021
|
05/27/2021
|
U01
|
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional) |
RFA-AI-20-064 |
See Related
|
NIAID |
10/07/2020 |
01/08/2021
|
02/09/2021
|
U01
|
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) |
RFA-AI-20-060 |
See Related
|
NIAID |
09/30/2020 |
01/04/2021
|
02/05/2021
|
U01
|
Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed) |
RFA-CA-20-043 |
See Related
|
NCI |
09/18/2020 |
12/20/2020
|
01/21/2021
|
U01
|
Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) |
RFA-MH-20-556 |
See Related
|
NIMH |
09/17/2020 |
01/11/2021
|
10/20/2021
|
U01
|
BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed) |
RFA-DK-20-506 |
See Related
|
NIDDK |
09/10/2020 |
01/09/2021
|
02/10/2021
|
U01
|
Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Clinical Centers (U01 Clinical Trial Required) |
RFA-TR-20-003 |
See Related
|
NCATS |
08/05/2020 |
08/06/2020
|
01/24/2021
|
U01
|
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) |
RFA-DA-21-006 |
See Related
|
NIDA |
07/17/2020 |
09/15/2020
|
10/15/2022
|
U01
|
BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed) |
RFA-CA-20-040 |
See Related
|
NCI |
07/02/2020 |
09/27/2020
|
02/18/2021
|
U01
|
Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed) |
RFA-DA-21-019 |
See Related
|
NIDA |
05/12/2020 |
06/20/2020
|
07/21/2021
|
U01
|
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed) |
RFA-NS-20-029 |
See Related
|
NINDS |
04/01/2020 |
06/14/2020
|
06/16/2021
|
U01
|
BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) |
RFA-OH-20-002 |
See Related
|
NIOSH |
11/21/2019 |
11/22/2019
|
01/30/2022
|
U01
|
Commercial Fishing Occupational Safety Research Cooperative Agreement (U01) |
RFA-CA-19-050 |
See Related
|
NCI |
09/05/2019 |
09/24/2019
|
06/24/2021
|
U01
|
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) |
RFA-EB-19-002 |
See Related
|
NIBIB |
06/27/2019 |
08/03/2019
|
09/04/2021
|
U01
|
BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial not allowed) |
RFA-NS-19-001 |
See Related
|
NINDS |
08/28/2018 |
10/14/2018
|
10/30/2021
|
U01
|
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required) |
RFA-NS-18-019 |
See Related
|
NINDS |
03/14/2018 |
04/15/2018
|
05/05/2021
|
U01
|
BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed) |
RFA-HS-21-001 |
See Related
|
AHRQ |
01/13/2021 |
01/13/2021
|
03/25/2021
|
U18
|
INTUIT-PC: Improving Nonsurgical Treatment of Urinary Incontinence among women in Primary Care: Dissemination and Implementation of PCOR Evidence (U18) |
RFA-TR-21-002 |
See Related
|
NCATS |
12/10/2020 |
06/08/2021
|
07/09/2021
|
U18
|
Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed) |
RFA-FD-18-001 |
See Related
|
FDA |
10/31/2017 |
11/06/2017
|
12/02/2021
|
U18
|
Flexible Funding Model - Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U18) |
RFA-AI-20-078 |
See Related
|
NIAID |
01/12/2021 |
05/04/2021
|
06/05/2021
|
U19
|
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) |
RFA-FD-21-009 |
See Related
|
FDA |
12/01/2020 |
12/03/2020
|
02/02/2021
|
U19
|
Renewal - Federal and University Partnership to Improve the Safety of Seafood from the Gulf of Mexico (U19 Clinical Trials Not Allowed) |
RFA-MH-21-165 |
See Related
|
NIMH |
10/15/2020 |
02/17/2021
|
03/18/2021
|
U19
|
From Genomic Association to Causation: A Convergent Neuroscience Approach to Linking Levels of Analysis for Understanding Neuropsychiatric Disorders (U19 Clinical Trial Optional) |
RFA-AI-20-056 |
See Related
|
NIAID |
10/08/2020 |
01/18/2021
|
02/19/2021
|
U19
|
Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed) |
RFA-NS-19-003 |
See Related
|
NINDS |
08/29/2018 |
09/30/2018
|
10/30/2021
|
U19
|
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed) |
RFA-DA-21-022 |
See Related
|
NIDA |
01/11/2021 |
03/01/2021
|
04/01/2021
|
U24
|
HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed) |
RFA-DA-21-023 |
See Related
|
NIDA |
01/11/2021 |
03/01/2021
|
04/01/2021
|
U24
|
HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24) |
RFA-HD-21-032 |
See Related
|
NICHD |
01/11/2021 |
02/28/2021
|
03/31/2021
|
U24
|
HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) |
RFA-RM-21-010 |
See Related
|
RMOD |
01/06/2021 |
02/08/2021
|
03/09/2021
|
U24
|
Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-AG-22-001 |
See Related
|
NIA |
12/14/2020 |
01/17/2021
|
02/18/2021
|
U24
|
Limited Competition: National Institute on Aging (NIA) Late Onset of Alzheimers Disease (LOAD) Family-Based Study (FBS) (U24 Clinical Trial Not Allowed) |
RFA-RM-20-023 |
See Related
|
RMOD |
12/08/2020 |
01/29/2021
|
03/02/2021
|
U24
|
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) |
RFA-CA-21-019 |
See Related
|
NCI |
12/02/2020 |
05/09/2021
|
11/19/2021
|
U24
|
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) |
RFA-CA-21-016 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U24
|
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
RFA-CA-21-015 |
See Related
|
NCI |
12/02/2020 |
05/08/2021
|
11/18/2021
|
U24
|
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
RFA-NS-21-004 |
See Related
|
NINDS |
11/23/2020 |
02/09/2021
|
03/10/2021
|
U24
|
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-DK-20-014 |
See Related
|
NIDDK |
11/23/2020 |
01/18/2021
|
02/19/2021
|
U24
|
Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed) |
RFA-CA-20-050 |
See Related
|
NCI |
10/14/2020 |
12/29/2020
|
01/30/2021
|
U24
|
New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-AA-20-012 |
See Related
|
NIAAA |
10/14/2020 |
04/26/2021
|
05/27/2021
|
U24
|
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional) |
RFA-AA-20-011 |
See Related
|
NIAAA |
10/14/2020 |
04/26/2021
|
05/27/2021
|
U24
|
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional) |
RFA-DK-20-509 |
See Related
|
NIDDK |
09/22/2020 |
01/09/2021
|
02/10/2021
|
U24
|
Limited Competition for Continuation of the Integrated Islet Distribution Program (U24 Clinical Trial Not Allowed) |
RFA-DK-20-507 |
See Related
|
NIDDK |
09/10/2020 |
01/09/2021
|
02/10/2021
|
U24
|
Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Scientific Data Research Center (U24 Clinical Trial Required) |
RFA-NS-19-006 |
See Related
|
NINDS |
10/22/2018 |
12/04/2018
|
06/28/2021
|
U24
|
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) |
RFA-CA-21-010 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
U2C
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
RFA-TR-21-010 |
See Related
|
NCATS |
01/13/2021 |
03/13/2021
|
01/13/2022
|
U44
|
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) |
RFA-NS-18-022 |
See Related
|
NINDS |
12/21/2017 |
01/23/2018
|
02/23/2021
|
U44
|
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required) |
RFA-NS-18-012 |
See Related
|
NINDS |
11/08/2017 |
01/21/2018
|
02/23/2021
|
U44
|
Translational Neural Devices (U44 - Clinical Trial Required) |
RFA-FD-21-011 |
See Related
|
FDA |
12/14/2020 |
12/14/2020
|
02/13/2021
|
U50
|
Renewal - Strengthen and Promote the Role of Local Health Departments in Retail Food Safety Regulation (U50 Clinical Trial Not Allowed |
RFA-RM-21-008 |
See Related
|
RMOD |
01/06/2021 |
02/08/2021
|
03/09/2021
|
U54
|
Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed) |
RFA-CA-21-002 |
See Related
|
NCI |
12/09/2020 |
02/18/2021
|
03/19/2021
|
U54
|
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed) |
RFA-RM-20-022 |
See Related
|
RMOD |
12/08/2020 |
01/28/2021
|
03/02/2021
|
U54
|
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) |
RFA-CA-21-009 |
See Related
|
NCI |
11/24/2020 |
01/22/2021
|
09/30/2021
|
U54
|
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) |
RFA-RM-20-015 |
See Related
|
RMOD |
07/24/2020 |
11/09/2020
|
02/09/2021
|
U54
|
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional) |
RFA-CA-20-029 |
See Related
|
NCI |
05/13/2020 |
08/28/2020
|
05/29/2021
|
U54
|
Metastasis Research Network (U54 Clinical Trial Not Allowed) |
RFA-CA-19-051 |
See Related
|
NCI |
09/06/2019 |
09/24/2019
|
06/24/2021
|
U54
|
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) |
RFA-OH-20-001 |
See Related
|
NIOSH |
11/04/2019 |
11/04/2019
|
02/19/2021
|
U60
|
Miner Safety and Health Training Program - Western United States (U60) |
RFA-HD-21-031 |
See Related
|
NICHD |
01/11/2021 |
02/28/2021
|
03/31/2021
|
UG1
|
HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required) |
RFA-TR-21-008 |
See Related
|
NCATS |
01/15/2021 |
03/19/2021
|
04/20/2021
|
UG3/UH3
|
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional) |
RFA-RM-21-009 |
See Related
|
RMOD |
01/06/2021 |
02/08/2021
|
03/09/2021
|
UG3/UH3
|
Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed) |
RFA-DE-21-002 |
See Related
|
NIDCR |
12/14/2020 |
01/10/2021
|
02/11/2021
|
UG3/UH3
|
Engaging the dental workforce to end the HIV epidemic in the U.S. (UG3/UH3 Clinical Trial Required) |
RFA-TR-21-001 |
See Related
|
NCATS |
12/10/2020 |
06/08/2021
|
07/09/2021
|
UG3/UH3
|
New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed) |
RFA-CA-20-049 |
See Related
|
NCI |
10/14/2020 |
12/29/2020
|
01/30/2021
|
UG3/UH3
|
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) |
RFA-NS-21-010 |
See Related
|
NINDS |
09/16/2020 |
10/18/2020
|
09/08/2022
|
UG3/UH3
|
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
RFA-MH-19-135 |
See Related
|
NIMH |
08/03/2018 |
09/09/2018
|
05/28/2021
|
UG3/UH3
|
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) |
RFA-NS-18-021 |
See Related
|
NINDS |
12/21/2017 |
01/23/2018
|
02/23/2021
|
UG3/UH3
|
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 - Clinical Trial Required) |
RFA-NS-18-011 |
See Related
|
NINDS |
11/08/2017 |
01/21/2018
|
02/23/2021
|
UG3/UH3
|
Translational Neural Devices (UG3/UH3 - Clinical Trial Required) |
RFA-NS-18-023 |
See Related
|
NINDS |
12/21/2017 |
01/23/2018
|
02/23/2021
|
UH3
|
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - Clinical Trial Required) |